Editors


Dr. Luc Duchesne

About Dr. Luc Duchesne

Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published 85 scientific papers, and has recently published his first novel, "The Moose Motel: A Tale of Golden Revenge". The Founder and CEO for GSN DreamWorks Inc. based in Ottawa, Luc is a regular columnist for InvestorIntel.

204 InvestorIntel Articles By Dr. Luc Duchesne

image_pdfimage_print

NanoSphere pioneering innovative cannabinoid delivery technology


March 05, 2018
| March 05, 2018 | 2 Comments

NanoSphere Health Sciences Inc. (CSE: NSHS) has developed an innovative delivery technology that increases up to six-fold the bioavailability of cannabinoids, […]


Cannabis prohibition hobbles science, causes needless suffering


February 19, 2018
| February 19, 2018

Attorney General Jeff Sessions has an uphill battle to maintain cannabis as a Schedule 1 drug. Last week in a […]


Squirrels for president: Debunking the frontiers of medical cannabis


February 11, 2018
| February 11, 2018

Cannabis is a fabulous medicine, yet we are still in the stone age of our understanding of its benefits and […]


Siyata Mobile: Highway to success


February 06, 2018
| February 06, 2018

Siyata Mobile Inc. (“Siyata”) (TSXV: SIM | OTCQX: SYATF) announced that is has secured contracts to sell its devices and […]


Kontrol looking to blockchain energy and greenhouse gas emissions


February 05, 2018
| February 05, 2018 | 1 Comment

Kontrol Energy Corp. (“Kontrol”) (CSE: KNR) announced that it has entered into a binding Letter of Intent (“LOI”) on January 31, […]


Cannabis bubble, THC cloud, and alternate reality


January 22, 2018
| January 22, 2018 | 2 Comments

Publically traded Canadian cannabis companies are doing exceptionally well. Common shares of Canopy Growth Corporation (WEED), the biggest cannabis company […]